Paper39697333
From promise to practice: CAR T and Treg cell therapies in autoimmunity and other immune-mediated diseases.
Bulliard Y and 6 others. Front Immunol, 2024. Cited by 34 papers, by iCite.
Cite this record
ConductScience Library. From promise to practice: CAR T and Treg cell therapies in autoimmunity and other immune-mediated diseases. Papers, record 39697333. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39697333
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- From promise to practice: CAR T and Treg cell therapies in autoimmunity and other immune-mediated diseases.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| T-Lymphocytes, Regulatory | Major topic |
| Autoimmune Diseases | Major topic |
| Immunotherapy, Adoptive | Major topic |
| Autoimmunity | Major topic |
| Receptors, Chimeric Antigen | Major topic |
| Humans | |
| Animals |
Source PubMed
References228
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33855972 | Selective expansion of regulatory T cells using an orthogonal IL-2/IL-2 receptor system facilitates transplantation tolerance. | J Clin Invest | 2021 | https://conductscience.org/library/papers/33855972 | PubMed |
| 2 | 37481700 | Dual-locus, dual-HDR editing permits efficient generation of antigen-specific regulatory T cells with robust suppressive activity. | Mol Ther | 2023 | https://conductscience.org/library/papers/37481700 | PubMed |
| 3 | 29385370 | Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia. | N Engl J Med | 2018 | https://conductscience.org/library/papers/29385370 | PubMed |
| 4 | 24321746 | Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients. | Biol Blood Marrow Transplant | 2014 | https://conductscience.org/library/papers/24321746 | PubMed |
| 5 | 39013470 | Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis. | Cell | 2024 | https://conductscience.org/library/papers/39013470 | PubMed |
| 6 | 28803861 | Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell Therapy. | Mol Ther | 2017 | https://conductscience.org/library/papers/28803861 | PubMed |
| 7 | 39231352 | Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus. | N Engl J Med | 2024 | https://conductscience.org/library/papers/39231352 | PubMed |
| 8 | 37834955 | Mesenchymal Stem Cell Therapy in Multiple Sclerosis: A Systematic Review and Meta-Analysis. | J Clin Med | 2023 | https://conductscience.org/library/papers/37834955 | PubMed |
| 9 | 18824594 | Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system. | Blood | 2009 | https://conductscience.org/library/papers/18824594 | PubMed |
| 10 | 29980618 | Revisiting IL-2: Biology and therapeutic prospects. | Sci Immunol | 2018 | https://conductscience.org/library/papers/29980618 | PubMed |
| 11 | 37295445 | Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004): a multicentre, open-label, single-arm, phase 1-2 study. | Lancet | 2023 | https://conductscience.org/library/papers/37295445 | PubMed |
| 12 | 38697115 | Treatment of concomitant myasthenia gravis and Lambert-Eaton myasthenic syndrome with autologous CD19-targeted CAR T cells. | Neuron | 2024 | https://conductscience.org/library/papers/38697115 | PubMed |
| 13 | 32864635 | Therapeutic Targeting of Follicular T Cells with Chimeric Antigen Receptor-Expressing Natural Killer Cells. | Cell Rep Med | 2020 | https://conductscience.org/library/papers/32864635 | PubMed |
| 14 | 22566933 | Molecular mechanisms of treg-mediated T cell suppression. | Front Immunol | 2012 | https://conductscience.org/library/papers/22566933 | PubMed |
| 15 | 16203864 | Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells. | J Exp Med | 2005 | https://conductscience.org/library/papers/16203864 | PubMed |
| 16 | 29593838 | B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targets. | Ther Adv Neurol Disord | 2018 | https://conductscience.org/library/papers/29593838 | PubMed |
| 17 | 31443677 | Mesenchymal stem cells for the treatment of ulcerative colitis: a systematic review and meta-analysis of experimental and clinical studies. | Stem Cell Res Ther | 2019 | https://conductscience.org/library/papers/31443677 | PubMed |
| 18 | 39874224 | CD19-CAR T-cell therapy induces deep tissue depletion of B cells. | Ann Rheum Dis | 2025 | https://conductscience.org/library/papers/39874224 | PubMed |
| 19 | 9180086 | HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. | Science | 1997 | https://conductscience.org/library/papers/9180086 | PubMed |
| 20 | 31900462 | 'Off-the-shelf' allogeneic CAR T cells: development and challenges. | Nat Rev Drug Discov | 2020 | https://conductscience.org/library/papers/31900462 | PubMed |
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42812913 | Immunotherapy of membranous nephropathy: strategic evolution from CD20 monoclonal antibodies to future vaccines. | Front Immunol | 2026 | https://conductscience.org/library/papers/42812913 | PubMed |
| 42756163 | Emerging CAR-Treg and regulatory T cell therapies for inflammatory bowel diseases: a systematic review of a new era of treatment. | Front Immunol | 2026 | https://conductscience.org/library/papers/42756163 | PubMed |
| 42656618 | CAR-T cells and CAR-Treg cells for treatment of inflammatory bowel diseases. | EULAR Rheumatol Open | 2026 | https://conductscience.org/library/papers/42656618 | PubMed |
| 42645190 | Regulatory T Cell (Treg): Central Orchestrator of Immune Homeostasis. | Cells | 2026 | https://conductscience.org/library/papers/42645190 | PubMed |
| 42548760 | Immunological heterogeneity in rheumatoid arthritis: challenges in early-stage stratification, non-response to targeted therapy, and the restoration of immune tolerance. | Front Immunol | 2026 | https://conductscience.org/library/papers/42548760 | PubMed |
| 42539630 | Emerging immune networks and targeted strategies in T2 asthma. | Front Immunol | 2026 | https://conductscience.org/library/papers/42539630 | PubMed |
| 42495646 | Engineering allogeneic type 1 regulatory T cells: a scalable, off-the-shelf platform for restoring immune tolerance. | Front Immunol | 2026 | https://conductscience.org/library/papers/42495646 | PubMed |
| 42491551 | Advancements in multiple myeloma treatment: Integrating quadruplet and dual antigen CAR-T therapy. | iScience | 2026 | https://conductscience.org/library/papers/42491551 | PubMed |
| 42380621 | Engineering immune cell therapies for inflammatory bowel disease: from stem cells to CAR T cells. | Nat Rev Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/42380621 | PubMed |
| 42191896 | T cell-targeted immunotherapies for multiple sclerosis: molecular mechanisms to therapeutic perspectives from Traditional Chinese medicine. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/42191896 | PubMed |
| 41953032 | Advancements and expanding applications of CAR-T cell therapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/41953032 | PubMed |
| 41878448 | Miniaturized IL-2/anti-IL-2 immunocytokines selectively activate and support the in vivo persistence of regulatory T cells. | Front Immunol | 2026 | https://conductscience.org/library/papers/41878448 | PubMed |
| 41756305 | Beyond cytokine blockade: could CAR-Tregs open a new era of tissue-targeted immune tolerance in psoriatic arthritis? | Front Immunol | 2026 | https://conductscience.org/library/papers/41756305 | PubMed |
| 41751878 | In Vivo CAR-T Therapies-A New Era of Programmable Immunity. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41751878 | PubMed |
| 41607801 | The immunobiology and therapeutic potential of regulatory T cells in autoimmune diseases and allergic diseases. | Front Immunol | 2025 | https://conductscience.org/library/papers/41607801 | PubMed |
| 41596556 | Engineering Immunity: Current Progress and Future Directions of CAR-T Cell Therapy. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41596556 | PubMed |
| 41522472 | Organ Transplantation: Current Status, Challenges, and Future Prospects. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/41522472 | PubMed |
| 41373685 | The Potential of β-Synuclein-Specific Regulatory T Cell Therapy as a Treatment for Progressive Multiple Sclerosis. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41373685 | PubMed |
| 41368361 | Cellular therapy in neuromyelitis optica spectrum disorder. | Front Neurol | 2025 | https://conductscience.org/library/papers/41368361 | PubMed |
| 41315911 | CAR T cell therapy in type 1 diabetes: what we know and what remains to be explored. | Biol Proced Online | 2025 | https://conductscience.org/library/papers/41315911 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD19 | 930 | PubTator's text mining | https://conductscience.org/library/genes/930 | NCBI Gene |
| FOXP3 | 50943 | PubTator's text mining | https://conductscience.org/library/genes/50943 | NCBI Gene |
| NR1I3 | 9970 | PubTator's text mining | https://conductscience.org/library/genes/9970 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39697333
GET https://conductscience.org/api/papers/v1/39697333/references?page=2